Optimization and evaluation of novel tetrahydropyrido[4,3-d]pyrimidine derivatives as ATX inhibitors for cardiac and hepatic fibrosis

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine · 2014 · 3.9K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Halogen Bonding—A Novel Interaction for Rational Drug Design?

Yunxiang Lu, Ting Shi, Yong Wang et al. · Journal of Medicinal Chemistry · 2009 · 557 citations · Full text

Natural Sciences, Chemistry, Medicinal Chemistry +13

Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial

Toby M. Maher, Ellen M. van der Aar, Olivier Van de Steen et al. · The Lancet Respiratory Medicine · 2018 · 235 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +7

Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress

Ji Hye Yang, Sang Chan Kim, Kyu Min Kim et al. · European Journal of Pharmacology · 2016 · 115 citations

Life Sciences, Cell Biology, Pharmacology +14

Resolution of bone marrow fibrosis in a patient receiving JAK1/JAK2 inhibitor treatment with ruxolitinib

Bridget S. Wilkins, D. Radia, C. Woodley et al. · Haematologica · 2013 · 78 citations · Full text

Medicine, Hematology, Pharmacology +15